Researchers from Texas A&M University’s College of Veterinary Medicine and Biomedical Sciences and the University of Minnesota have received a $3.8 million grant from the National Institutes of Health to develop antiviral treatments for mpox, formerly known as monkeypox. The disease, which causes rashes and blisters, remains a significant public health concern in parts of Central and Eastern Africa, where it is endemic
Fair Use Notice
UNMC Global Center for Health Security staff curate publicly available news and information for educational and informational purposes. Brief excerpts of published articles may be displayed under principles of Fair Use, with credit and links provided to the source publications. All copyrights remain the property of their respective owners.